YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Haele, Matthias, Moya, Iván M., Karaman, Ruçhan, Rens, Guy, Snoeck, Janne, Govaere, Olivier, Nevens, Frederik, Verslype, Chris, Topal, Baki, Monbaliu, Diethard, Halder, Georg, Roskams, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386931/
https://www.ncbi.nlm.nih.gov/pubmed/30717258
http://dx.doi.org/10.3390/ijms20030638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386931/
https://www.ncbi.nlm.nih.gov/pubmed/30717258
http://dx.doi.org/10.3390/ijms20030638

Ejemplares similares